rVWF: treatment finally reaches the modern age.
Ara D Metjian
View on PubMed
Abstract & Figures
In this issue of Blood, Gill et al describe the results of the first phase 3 clinical trial evaluating recombinant von Willebrand factor (rVWF) for the treatment of hemorrhagic events in all patients with von Willebrand disease (VWD).
VWF wt Allele
Figures and Tables
Sorry, we couldn't extract any figures or tables for this paper.
Sorry, we couldn't extract any citations for this paper.
Sorry, we couldn't extract any references for this paper.
Loading similar papers…
Slides referencing similar topics
Advances in the Treatment of Intracerebral Hemorrhage
Lauren H. Sansing • Oct 20, 2017
Treatment for Hemorrhagic Stroke
Joseph T. Ho • Nov 06, 2017
Modern Management of Intracerebral Hemorrhage Natasha Renda
Nov 07, 2017